SARTORIUS STED BIO (DIM)

SARTORIUS STED BIO

Sell: €204.00|Buy: €206.50|Change: 0.60 (0.29%)

Open

€203.00

Previous close

€203.70

Trade high

€206.20

Volume

131,891

Year high

€239.80

Year low

€148.75

Dividend yield

0.34%

Market capitalisation

€19.88 bn

P/E ratio

75.17

ISIN

FR0013154002

This share can be held in a Dealing account SIPP

Share price

Performance 17/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
SARTORIUS STED BIO	- 2.11
More...

Company profile

Sartorius Stedim Biotech is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs and has a focus on single-use technology. It is a subsidiary of Sartorius AG, which has 71.5% ownership and 83% voting control. The business is geographically diverse, with 35% of sales from the Americas, 42% from Europe, the Middle East, and Africa,15% from Asia excluding China, and 8% from China.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.